Join the club for FREE to access the whole archive and other member benefits.

Everon Biosciences

Biotechnology company specializing in the development of novel anti-aging therapeutics

Everon Biosciences, Inc. was founded in 2010 with the goal of developing anti-aging medicines. Company’s scientific program and vision are based on principles of eradicating the cellular foundations of aging formulated by Prof. Andrei Gudkov, Senior Vice President of Research Programming and Development of Roswell Park Cancer Institute, the world’s oldest cancer research center. From the very beginning, the institute has been Everon’s supportive shareholder and a reliable partner, providing access to its rich technical infrastructure and its scientists and physicians. This strategic collaboration resulted in the development of pharmacological and immunological approaches to treatment of age-related frailty. Everon holds a unique position among recently launched anti-aging companies in its approach to the treatment of aging from all major R&D aspects: mechanistic understanding of aging process, access to targets, availability of proprietary drug candidates, strong preclinical efficacy indications, the development of diagnostic tools and clinical strategy.

Visit website: http://everonbio.com/

 Login to view link, or join the club to get full access to all resources and other benefits.

 Login to view link, or join the club to get full access to all resources and other benefits.

 Login to view link, or join the club to get full access to all resources and other benefits.

Everon Biosciences News

Fight Aging predicts the sequence of arrival for meaningful antiaging therapies

Next Big Future - 01-Dec-2016

Each treatment will target a different type of molecular damage in cells and tissues. 1) Clearan...

Read more...